Automated 3D organoid screening technology

We integrate standard assays on chip (eg. CRISPR, T-cell, cytotoxicity) to accelerate drug discovery from target to validation, and advance preclinical predictivity.

Contact us
Okomera's CTO using the machine in the laboratory

Multiplexing

+100 conditions / batch

Miniaturization

Only 5,000 cells / chip

Quick

~1 week

Automated

No expertise needed

Publications

Take a look at our publications

Combinatorial drug screening on 3D Ewing sarcoma spheroids using droplet-based microfluidics
2023

Combinatorial drug screening on 3D Ewing sarcoma spheroids using droplet-based microfluidics

High resolution microfluidic assay and probabilistic modeling reveal cooperation between T cells in tumor killing
2022

High resolution microfluidic assay and probabilistic modeling reveal cooperation between T cells in tumor killing

Evaluating immune response in vitro in a relevant microenvironment: a high-throughput microfluidic model for clinical screening
2022

Evaluating immune response in vitro in a relevant microenvironment: a high-throughput microfluidic model for clinical screening

Browse all news and articles

Explore the future of drug discovery. Start today!

Our Partners